New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 9, 2014
09:27 EDTXOMAXOMA data extremely encouraging, says Roth Capital
Roth Capital believes that data for XOMA's anti-IL-1b antibody gevokizumab in pyoderma gangrenosum was "extremely encouraging." The firm expects investors' appreciation for the company to increase as its antibody platform develops, and it keeps a Buy rating on the stock.
News For XOMA From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 3, 2015
07:19 EDTXOMAXOMA CFO Fred Kurland to retire, Thomas Burns to succeed
XOMA announced Thomas Burns, vice president, Finance, will succeed Fred Kurland as CFO when Kurland retires from his role as vice president, Finance, CFO and Secretary effective April 3. Burns joined the XOMA finance team in 2006.
February 24, 2015
07:31 EDTXOMARBC Capital to hold a conference
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use